State Street Corp Denali Therapeutics Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 4,434,790 shares of DNLI stock, worth $127 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,434,790

Previous 6,323,872 29.87%

Holding current value

$127 Million

Previous $130 Million 20.65%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $28.3 Million - $43.9 Million	-1,889,082 Reduced 29.87%	4,434,790 $103 Million
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $13.3 Million - $19.6 Million	837,924 Added 15.27%	6,323,872 $130 Million
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $19.6 Million - $28.1 Million	1,210,620 Added 28.32%	5,485,948 $118 Million
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $3.98 Million - $5.83 Million	-193,163 Reduced 4.32%	4,275,328 $88.2 Million
Q2 2023 Aug 14, 2023	SELL	$23.37 - $32.96 $2.87 Million - $4.05 Million	-122,898 Reduced 2.68%	4,468,491 $132 Million
Q1 2023 May 15, 2023	SELL	$21.91 - $32.67 $5.57 Million - $8.31 Million	-254,421 Reduced 5.25%	4,591,389 $106 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $17.2 Million - $22.2 Million	653,582 Added 15.59%	4,845,810 $135 Million
Q3 2022 Nov 15, 2022	BUY	$25.97 - $38.53 $11.5 Million - $17 Million	441,528 Added 11.77%	4,192,228 $129 Million
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $1.59 Million - $2.68 Million	-76,092 Reduced 1.99%	3,750,700 $110 Million
Q1 2022 May 16, 2022	BUY	$29.0 - $47.27 $23.2 Million - $37.8 Million	799,221 Added 26.4%	3,826,792 $123 Million
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $9.77 Million - $12.6 Million	229,437 Added 8.2%	3,027,571 $135 Million
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $23.2 Million - $37.4 Million	477,674 Added 20.59%	2,798,134 $141 Million
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $15.3 Million - $23.8 Million	303,793 Added 15.06%	2,320,460 $182 Million
Q1 2021 May 17, 2021	SELL	$53.8 - $81.53 $2.71 Million - $4.11 Million	-50,406 Reduced 2.44%	2,016,667 $115 Million
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $6.95 Million - $17.6 Million	-188,526 Reduced 8.36%	2,067,073 $173 Million
Q3 2020 Nov 10, 2020	BUY	$23.13 - $38.84 $238,678 - $400,789	10,319 Added 0.46%	2,255,599 $80.8 Million
Q2 2020 Aug 14, 2020	BUY	$16.01 - $28.82 $8.89 Million - $16 Million	555,524 Added 32.88%	2,245,280 $54.3 Million
Q1 2020 May 11, 2020	BUY	$14.2 - $27.98 $24 Million - $47.3 Million	1,689,756 New	1,689,756 $29.6 Million

Others Institutions Holding DNLI

# of Institutions

214

Shares Held

121M

Call Options Held

127K

Put Options Held

38.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.85B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Denali Therapeutics Inc. Transaction History